The U.S. Pharmaceutical Industry Under the Shadow of Tariffs: Corporate Hoarding for Self-Preservation and the Public's Struggle with Rising Drug Costs
Against the backdrop of a seismic shift in the global trade landscape in 2025, the U.S. pharmaceutical industry is mired in a survival crisis triggered by tariff policies.
more